HCW Biologics (HCWB) Misses Q2 EPS by 679c

HCW Biologics (NASDAQ: HCWB) reported Q2 EPS of ($6.79). Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on HCW Biologics (HCWB) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• ILC Critical Minerals closes $382,500 private placement
• Hyperscale Data reports Bitcoin treasury of 726.9 BTC worth $45.9M